IRIS Accounts Production v22.1.0.628 12481219 Board of Directors Board of Directors 1.3.22 28.2.23 28.2.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure124812192022-02-28124812192023-02-28124812192022-03-012023-02-28124812192021-02-28124812192021-03-012022-02-28124812192022-02-2812481219ns16:EnglandWales2022-03-012023-02-2812481219ns15:PoundSterling2022-03-012023-02-2812481219ns11:Director12022-03-012023-02-2812481219ns11:Director22022-03-012023-02-2812481219ns11:PrivateLimitedCompanyLtd2022-03-012023-02-2812481219ns11:Micro-entities2022-03-012023-02-2812481219ns11:AuditExempt-NoAccountantsReport2022-03-012023-02-2812481219ns11:FullAccounts2022-03-012023-02-2812481219ns6:CurrentFinancialInstruments2023-02-2812481219ns6:CurrentFinancialInstruments2022-02-2812481219ns11:RegisteredOffice2022-03-012023-02-2812481219ns11:Director112022-02-2812481219ns11:Director112021-02-2812481219ns11:Director112022-03-012023-02-2812481219ns11:Director112021-03-012022-02-2812481219ns11:Director112023-02-2812481219ns11:Director112022-02-28124812192ns11:Director22022-02-28124812192ns11:Director22021-02-28124812192ns11:Director22022-03-012023-02-28124812192ns11:Director22021-03-012022-02-28124812192ns11:Director22023-02-28124812192ns11:Director22022-02-28
REGISTERED NUMBER: 12481219 (England and Wales)















Financial Statements for the Year Ended 28 February 2023

for

Indigo Life Sciences Ltd

Indigo Life Sciences Ltd (Registered number: 12481219)






Contents of the Financial Statements
for the Year Ended 28 February 2023




Page

Statement of Financial Position 1


Indigo Life Sciences Ltd (Registered number: 12481219)

Statement of Financial Position
28 February 2023

28.2.23 28.2.22
£    £    £    £   
FIXED ASSETS 7,655 4,658

CURRENT ASSETS 89,676 282,749

CREDITORS
Amounts falling due within one year (15,679 ) (86,427 )
NET CURRENT ASSETS 73,997 196,322
TOTAL ASSETS LESS CURRENT
LIABILITIES

81,652

200,980

CAPITAL AND RESERVES 81,652 200,980

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Indigo Life Sciences Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12481219

Registered office: XL House
2 Mill Court
Spindle Way
Crawley
Sussex
RH10 1TT

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 4 (2022 - 4 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 28 February 2023 and 28 February 2022:

28.2.23 28.2.22
£    £   
C M Phethean
Balance outstanding at start of year (3,405 ) (3,405 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,405 ) (3,405 )

Indigo Life Sciences Ltd (Registered number: 12481219)

Statement of Financial Position - continued
28 February 2023

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

E Pooley
Balance outstanding at start of year (3,004 ) (3,004 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,004 ) (3,004 )



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 14 November 2023 and were signed on its behalf by:




C M Phethean - Director



E Pooley - Director